98%(TLC)" />
Pharmacology: p53 activator. Restores wild-type p53 signaling and depletes mutant p53?gain of function.
Induces mutant p53 protein degradation via MDM2 and ubiquitin-proteasome pathway.
Induces p73-dependent cell death in cancer cells without toxicity?toward normal cells1
?Inhibition of p53-MDM2 interaction remains a viable strategy for cancer?therapeutic development2,3
References:
1. S Zhang et al. Cancer Res. 2015 75:3842
2. M Ferraiuolo et al. Front Oncol. 2016 6:77
3. B Hong et al. Curr. Drug Targets 2014 15:80
?
BIOLEAF熱搜 BIOLEAF試劑盒 BIOLEAF ELISA BIOLEAF試劑 BIOLEAF品牌 BIOLEAF抗體 BIOLEAF耗材 BIOLEAF小儀器
sitemap 細胞庫查詢 危險品圖標 本公司網(wǎng)站所展示銷售的產(chǎn)品僅供科研!
滬公網(wǎng)安備 31011202007338號